• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

克里斯滕森菌属菌株资源、基因组/代谢组学分析及其在种水平与宿主的关联。

Christensenella strain resources, genomic/metabolomic profiling, and association with host at species level.

机构信息

State Key Laboratory of Microbial Technology, Shandong University, Qingdao, P. R. China.

College of Veterinary Medicine, Shanxi Agr icultural University, Taigu, China.

出版信息

Gut Microbes. 2024 Jan-Dec;16(1):2347725. doi: 10.1080/19490976.2024.2347725. Epub 2024 May 9.

DOI:10.1080/19490976.2024.2347725
PMID:38722028
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11085954/
Abstract

The gut commensal bacteria species are negatively associated with many metabolic diseases, and have been seen as promising next-generation probiotics. However, the cultured strain resources were limited, and their beneficial mechanisms for improving metabolic diseases have yet to be explored. In this study, we developed a method that enabled the enrichment and cultivation of strains from fecal samples. Using this method, a collection of Gut Microbial Biobank (ChrisGMB) was established, composed of 87 strains and genomes that represent 14 species of 8 genera. Seven species were first described and the cultured resources have been significantly expanded at species and strain levels. strains exerted different abilities in utilization of various complex polysaccharides and other carbon sources, exhibited host-adaptation capabilities such as acid tolerance and bile tolerance, produced a wide range of volatile probiotic metabolites and secondary bile acids. Cohort analyses demonstrated that and were prevalent in various cohorts and the abundances were significantly reduced in T2D and OB cohorts. At species level, showed different changes among healthy and disease cohorts. , , , and significantly reduced in all the metabolic disease cohorts. The relative abundances of and showed no significant change in NAFLD and ACVD. and and showed no significant change in ACVD, and and showed no significant change in NAFLD, when compared with the HC cohort. So far as we know, this is the largest collection of cultured resource and first exploration of prevalences and abundances at species level.

摘要

肠道共生细菌种类与许多代谢性疾病呈负相关,被视为有前途的下一代益生菌。然而,可培养的菌株资源有限,其改善代谢性疾病的有益机制仍有待探索。在本研究中,我们开发了一种从粪便样本中富集和培养菌株的方法。利用这种方法,建立了一个肠道微生物生物库(ChrisGMB),其中包含 87 株代表 8 个属 14 个种的菌株和基因组。其中 7 个种是首次描述的,在种和株水平上可培养资源得到了显著扩展。菌株在利用各种复杂多糖和其他碳源方面表现出不同的能力,表现出耐酸和耐胆盐等宿主适应能力,产生广泛的挥发性益生菌代谢物和次级胆汁酸。队列分析表明,在各种队列中都普遍存在 和 ,并且在 T2D 和 OB 队列中丰度显著降低。在种水平上,健康和疾病队列中 的变化不同。在所有代谢性疾病队列中, 、 、 、 和 显著减少。在 NAFLD 和 ACVD 中, 和 相对丰度没有显著变化。在 ACVD 中, 和 没有显著变化,在 NAFLD 中, 和 没有显著变化,与 HC 队列相比。据我们所知,这是最大的可培养资源集合,也是首次在种水平上探索 的流行率和丰度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfa8/11085954/f8415c29ac8a/KGMI_A_2347725_F0006_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfa8/11085954/44771a6118e0/KGMI_A_2347725_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfa8/11085954/579c44b8eae8/KGMI_A_2347725_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfa8/11085954/93a5b8ae201e/KGMI_A_2347725_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfa8/11085954/444e72605740/KGMI_A_2347725_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfa8/11085954/f555f093fde0/KGMI_A_2347725_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfa8/11085954/f8415c29ac8a/KGMI_A_2347725_F0006_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfa8/11085954/44771a6118e0/KGMI_A_2347725_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfa8/11085954/579c44b8eae8/KGMI_A_2347725_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfa8/11085954/93a5b8ae201e/KGMI_A_2347725_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfa8/11085954/444e72605740/KGMI_A_2347725_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfa8/11085954/f555f093fde0/KGMI_A_2347725_F0005_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfa8/11085954/f8415c29ac8a/KGMI_A_2347725_F0006_OC.jpg

相似文献

1
Christensenella strain resources, genomic/metabolomic profiling, and association with host at species level.克里斯滕森菌属菌株资源、基因组/代谢组学分析及其在种水平与宿主的关联。
Gut Microbes. 2024 Jan-Dec;16(1):2347725. doi: 10.1080/19490976.2024.2347725. Epub 2024 May 9.
2
The keystone gut species boosts gut microbial biomass and voluntary physical activity in mice.关键肠道菌物种可促进肠道微生物生物量和小鼠的自愿体力活动。
mBio. 2024 Feb 14;15(2):e0283623. doi: 10.1128/mbio.02836-23. Epub 2023 Dec 22.
3
Syntrophy via Interspecies H Transfer between and Underlies Their Global Cooccurrence in the Human Gut.种间 H 转移共生使 在人类肠道中全球共存。
mBio. 2020 Feb 4;11(1):e03235-19. doi: 10.1128/mBio.03235-19.
4
, a new candidate next-generation probiotic: current evidence and future trajectories.一种新型候选下一代益生菌:当前证据与未来发展轨迹
Front Microbiol. 2024 Jan 11;14:1241259. doi: 10.3389/fmicb.2023.1241259. eCollection 2023.
5
Reclassification of as comb. nov. based on whole genome analysis.根据全基因组分析,将 重新分类为 组合新种。
Int J Syst Evol Microbiol. 2021 Apr;71(4). doi: 10.1099/ijsem.0.004774.
6
A New Strain of as a Potential Biotherapy for Obesity and Associated Metabolic Diseases.一种新型 ,有望成为肥胖症及相关代谢性疾病的生物疗法。
Cells. 2021 Apr 6;10(4):823. doi: 10.3390/cells10040823.
7
interacts with multiple gut bacteria.与多种肠道细菌相互作用。
Front Microbiol. 2024 Feb 19;15:1301073. doi: 10.3389/fmicb.2024.1301073. eCollection 2024.
8
Human genetics shape the gut microbiome.人类遗传学塑造了肠道微生物组。
Cell. 2014 Nov 6;159(4):789-99. doi: 10.1016/j.cell.2014.09.053.
9
Description and genomic characterization of Massiliimalia massiliensis gen. nov., sp. nov., and Massiliimalia timonensis gen. nov., sp. nov., two new members of the family Ruminococcaceae isolated from the human gut.从人类肠道分离出的瘤胃球菌科两个新成员——马西利马利亚菌属马西利马利亚种新属新种及蒂蒙马西利马利亚菌属蒂蒙马西利马利亚种新属新种的描述与基因组特征分析
Antonie Van Leeuwenhoek. 2019 Jun;112(6):905-918. doi: 10.1007/s10482-018-01223-x. Epub 2019 Jan 28.
10
Comprehensive analyses of a large human gut Bacteroidales culture collection reveal species- and strain-level diversity and evolution.对大型人类肠道拟杆菌培养物集的综合分析揭示了种属和菌株水平的多样性和进化。
Cell Host Microbe. 2024 Oct 9;32(10):1853-1867.e5. doi: 10.1016/j.chom.2024.08.016. Epub 2024 Sep 17.

引用本文的文献

1
Genomic insights and metabolic profiling of gut commensal Luoshenia tenuis at strain level.菌株水平上肠道共生菌纤细罗氏菌的基因组见解与代谢谱分析
NPJ Biofilms Microbiomes. 2025 Aug 5;11(1):153. doi: 10.1038/s41522-025-00793-9.
2
Multi-omics reveals EGCG's anti-calcification effects associated with gut microbiota and metabolite remodeling.多组学揭示表没食子儿茶素没食子酸酯与肠道微生物群和代谢物重塑相关的抗钙化作用。
Front Immunol. 2025 Jun 26;16:1595527. doi: 10.3389/fimmu.2025.1595527. eCollection 2025.
3
Probiotic Lactobacillus rhamnosus GG Alleviates Prehypertension and Restores Gut Health and Microbiota in NaCl-Induced Prehypertensive Rats.

本文引用的文献

1
Metabolite profiling of human-originated Lachnospiraceae at the strain level.人类源毛螺菌科菌株水平的代谢物谱分析。
Imeta. 2022 Oct 13;1(4):e58. doi: 10.1002/imt2.58. eCollection 2022 Dec.
2
Gut commensal Christensenella minuta modulates host metabolism via acylated secondary bile acids.肠道共生Christensenella minuta 通过酰化次级胆汁酸调节宿主代谢。
Nat Microbiol. 2024 Feb;9(2):434-450. doi: 10.1038/s41564-023-01570-0. Epub 2024 Jan 17.
3
Traditional Medicine Pien Tze Huang Suppresses Colorectal Tumorigenesis Through Restoring Gut Microbiota and Metabolites.
益生菌鼠李糖乳杆菌GG可缓解盐诱导的高血压前期大鼠的高血压前期状态,并恢复其肠道健康和微生物群。
Probiotics Antimicrob Proteins. 2025 Apr 20. doi: 10.1007/s12602-025-10536-z.
4
Gut microbiota differences, metabolite changes, and disease intervention during metabolic - dysfunction - related fatty liver progression.代谢功能障碍相关脂肪性肝病进展过程中的肠道微生物群差异、代谢物变化及疾病干预
World J Hepatol. 2025 Mar 27;17(3):103854. doi: 10.4254/wjh.v17.i3.103854.
5
Deciphering the coordinated roles of the host genome, duodenal mucosal genes, and microbiota in regulating complex traits in chickens.解析宿主基因组、十二指肠黏膜基因和微生物群在调节鸡复杂性状中的协同作用。
Microbiome. 2025 Mar 1;13(1):62. doi: 10.1186/s40168-025-02054-5.
6
MetOrigin 2.0: Advancing the discovery of microbial metabolites and their origins.MetOrigin 2.0:推动微生物代谢产物及其来源的发现
Imeta. 2024 Nov 6;3(6):e246. doi: 10.1002/imt2.246. eCollection 2024 Dec.
传统中药片仔癀通过恢复肠道微生物群和代谢物来抑制结直肠肿瘤发生。
Gastroenterology. 2023 Dec;165(6):1404-1419. doi: 10.1053/j.gastro.2023.08.052. Epub 2023 Sep 12.
4
Carbohydrate quality, fecal microbiota and cardiometabolic health in older adults: a cohort study.碳水化合物质量、粪便微生物群与老年人的心脏代谢健康:一项队列研究。
Gut Microbes. 2023 Dec;15(2):2246185. doi: 10.1080/19490976.2023.2246185.
5
Hyodeoxycholic acid alleviates non-alcoholic fatty liver disease through modulating the gut-liver axis.熊去氧胆酸通过调节肠-肝轴缓解非酒精性脂肪性肝病。
Cell Metab. 2023 Oct 3;35(10):1752-1766.e8. doi: 10.1016/j.cmet.2023.07.011. Epub 2023 Aug 16.
6
Depletion of butyrate-producing microbes of the Firmicutes predicts nonresponse to FMT therapy in patients with recurrent infection.梭菌Firmicutes 中丁酸盐产生菌的耗竭可预测复发性感染患者对 FMT 治疗无反应。
Gut Microbes. 2023 Jan-Dec;15(1):2236362. doi: 10.1080/19490976.2023.2236362.
7
A Keystone Gut Bacterium -A Potential Biotherapeutic Agent for Obesity and Associated Metabolic Diseases.一种关键肠道细菌——肥胖及相关代谢性疾病的潜在生物治疗剂。
Foods. 2023 Jun 26;12(13):2485. doi: 10.3390/foods12132485.
8
Strain dropouts reveal interactions that govern the metabolic output of the gut microbiome.压力消除揭示了控制肠道微生物组代谢产出的相互作用。
Cell. 2023 Jun 22;186(13):2839-2852.e21. doi: 10.1016/j.cell.2023.05.037.
9
Inhibitory effects of culture and supernatant on inflammatory colorectal cancer in mice.培养物和上清液对炎性结直肠癌小鼠的抑制作用。
Front Immunol. 2023 Apr 4;14:1004756. doi: 10.3389/fimmu.2023.1004756. eCollection 2023.
10
Effects of Caprylic Acid and Eicosapentaenoic Acid on Lipids, Inflammatory Levels, and the JAK2/STAT3 Pathway in ABCA1-Deficient Mice and ABCA1 Knock-Down RAW264.7 Cells.辛酸和二十碳五烯酸对 ABCA1 缺陷型小鼠和 ABCA1 敲低 RAW264.7 细胞的脂质、炎症水平和 JAK2/STAT3 通路的影响。
Nutrients. 2023 Mar 6;15(5):1296. doi: 10.3390/nu15051296.